Vascular injury and vessel wall diseases serve as triggers for the accumulation of platelets and fibrin, sometimes with disastrous consequences. Platelet activation mechanisms are commonly studied in vitro using tools that work best at the level of individual platelets or small groups of platelets. Here we have made a paradigm shift, viewing both hemostatic and pathologic thrombus formation as the product of large platelet populations and combining observational, experimental and computational approaches to understand the relationships among those populations. Our overall goal is to obtain new insights into platelet activation as it occurs in vivo and identify better ways to limit thrombosis without overly impairing hemostasis. Our premise is that as platelets begin to accumulate at a site of injury, they alter their local microenvironment in ways that affect subsequent events. We and others have shown previously that there are regional differences in the extent of platelet activation within hemostatic thrombi, resulting in a core of fully-activated, closely-packed platelets overlaid by a shell of less-activated platelets. Here we hope to understand how these regional differences arise and influence subsequent thrombus growth and stability.
In Aim #1 we will apply novel technologies to determine how regional differences in platelet packing density, intrathrombus solute transport and agonist distribution arise and interact with the platelet signaling network.
In Aim #2, we will collaborate with fellow PPG members, Sriram Krishnaswamy and Rodney Camire, to test the hypothesis that thrombus architecture, as well as the location of procoagulant membranes, dictate the distribution of thrombin and fibrin during the hemostatic response. Finally, in Aim #3 we will combine observational and experimental data from Aims #1 and #2 with computational methods to test hypotheses about thrombus formation that cannot be addressed by experimental approaches alone, including the hypothesis that the formation of a core-and-shell architecture is a biological mechanism evolved to limit thrombus growth and prevent vascular occlusion. All three aims are built upon considerable preliminary data and take advantage of new and existing methods to study thrombus formation. They will also take advantage of the collective expertise of a team of investigators with strong backgrounds in platelet biology, mouse models of hemostasis, methods development, and the use of computational and applied engineering approaches to answer biological questions.

Public Health Relevance

Project 3 - Narrative Platelet activation is part of the normal response to vascular injury, producing a plug that limits blood loss. Thrombosis occurs when platelets are activated inappropriately, blocking blood flow and damaging tissues such as the heart and brain. The goal of this project is to better understand the molecular basis of platelet activation and translate that understanding into improved methods to prevent thrombosis.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
United States
Zip Code
Mirramezani, M; Herbig, B A; Stalker, T J et al. (2018) Platelet packing density is an independent regulator of the hemostatic response to injury. J Thromb Haemost 16:973-983
Capitano, Maegan; Zhao, Liang; Cooper, Scott et al. (2018) Phosphatidylinositol transfer proteins regulate megakaryocyte TGF-?1 secretion and hematopoiesis in mice. Blood 132:1027-1038
Branchford, B R; Stalker, T J; Law, L et al. (2018) The small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis. J Thromb Haemost 16:352-363
Bergmeier, Wolfgang; Stefanini, Lucia (2018) Platelets at the Vascular Interface. Res Pract Thromb Haemost 2:27-33
Zhao, Baobing; Mei, Yang; Cao, Lan et al. (2018) Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms. J Clin Invest 128:125-140
Yago, Tadayuki; Zhang, Nan; Zhao, Liang et al. (2018) Selectins and chemokines use shared and distinct signals to activate ?2 integrins in neutrophils. Blood Adv 2:731-744
Stefanini, L; Bergmeier, W (2018) Negative regulators of platelet activation and adhesion. J Thromb Haemost 16:220-230
Xie, Zhigang; Hur, Seong Kwon; Zhao, Liang et al. (2018) A Golgi Lipid Signaling Pathway Controls Apical Golgi Distribution and Cell Polarity during Neurogenesis. Dev Cell 44:725-740.e4
Paul, David S; Casari, Caterina; Wu, Congying et al. (2017) Deletion of the Arp2/3 complex in megakaryocytes leads to microthrombocytopenia in mice. Blood Adv 1:1398-1408
Welsh, J D; Poventud-Fuentes, I; Sampietro, S et al. (2017) Hierarchical organization of the hemostatic response to penetrating injuries in the mouse macrovasculature. J Thromb Haemost 15:526-537

Showing the most recent 10 out of 52 publications